Ceros Capital Markets

Ceros Capital Markets

Miami, Floridacerosfs.com

Overview

Ceros Capital Markets specializes in fundraising (primarily Series A-D) for MedTech companies that are developing disruptive technologies, particularly for diagnostic and non-invasive procedures in the medical device, robotic, biotech, and digital health sectors . Ceros clients have the opportunity to invest in companies that are pushing the boundaries of technology, disrupting the medical industry, and fueling innovation to help change lives .

Portfolio Companies

5

Investments

CompanyDateStageLead
Cordio MedicalJan 2024SAFECo-investor
GT Metabolic SolutionsNov 2023Series BCo-investor
GT Metabolic SolutionsJul 2022Series ALead
Cordio MedicalJun 2022Series CLead
AQUYRE BiosciencesNov 2021Series A ExtensionCo-investor

Key People

Andrew Massaro

Junior Partner

CRCP® Daniel Wilson

Communications Principal AML Officer

David Styfco

Registered Principal

Eric Hilderbrand

Registered Principal

Manuel Klemm

Licensing Principal

Chris Dewey

Partner, Venture Capital Markets

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMiami, Florida
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.